Zillikens D - Search Results

1

Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

Schmidt E, Obe K, Bröcker EB, Zillikens D. Schmidt E, et al. Among authors: zillikens d. Arch Dermatol. 2000 Feb;136(2):174-8. doi: 10.1001/archderm.136.2.174. Arch Dermatol. 2000. PMID: 10677092 Clinical Trial.

2

High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid.

Schmidt E, Bröcker EB, Zillikens D. Schmidt E, et al. Among authors: zillikens d. Arch Dermatol. 1995 Aug;131(8):966-7. Arch Dermatol. 1995. PMID: 7632081 No abstract available.

3

[Bullous pemphigoid simulation subacute simple prurigo].

Wever S, Rank C, Hornschuh B, Hashimoto T, Nishikawa T, Bröcker EB, Zillikens D. Wever S, et al. Among authors: zillikens d. Hautarzt. 1995 Nov;46(11):789-95. doi: 10.1007/s001050050340. Hautarzt. 1995. PMID: 8641886 German.

4

Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects.

Schmidt E, Ambach A, Bastian B, Bröcker EB, Zillikens D. Schmidt E, et al. Among authors: zillikens d. J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):310-2. doi: 10.1016/s0190-9622(96)80146-0. J Am Acad Dermatol. 1996. PMID: 8642104 No abstract available.

5

A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.

Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Bröcker EB, Hashimoto T. Zillikens D, et al. J Invest Dermatol. 1996 Mar;106(3):465-70. doi: 10.1111/1523-1747.ep12343631. J Invest Dermatol. 1996. Corrected and republished in: J Invest Dermatol. 1996 Jun;106(6):1333-8. doi: 10.1111/1523-1747.ep12349283 PMID: 8648178 Free article. Corrected and republished.

6

A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.

Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T. Zillikens D, et al. J Invest Dermatol. 1996 Jun;106(6):1333-8. doi: 10.1111/1523-1747.ep12349283. J Invest Dermatol. 1996. PMID: 8752680 Free article.

7

Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

Schmidt E, Bastian B, Dummer R, Tony HP, Bröcker EB, Zillikens D. Schmidt E, et al. Among authors: zillikens d. Arch Dermatol Res. 1996 Jun;288(7):353-7. doi: 10.1007/BF02507102. Arch Dermatol Res. 1996. PMID: 8818181

8

Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid.

Schmidt E, Mittnacht A, Schömig H, Dummer R, Bröcker EB, Zillikens D. Schmidt E, et al. Among authors: zillikens d. J Dermatol Sci. 1996 Feb;11(2):142-7. doi: 10.1016/0923-1811(95)00435-1. J Dermatol Sci. 1996. PMID: 8869035

9

Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.

Hornschuh B, Hamm H, Wever S, Hashimoto T, Schröder U, Bröcker EB, Zillikens D. Hornschuh B, et al. Among authors: zillikens d. J Am Acad Dermatol. 1997 Jan;36(1):101-3. doi: 10.1016/s0190-9622(97)70336-0. J Am Acad Dermatol. 1997. PMID: 8996271 No abstract available.

10

Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.

Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, Callen JP, Bröcker EB, Diaz LA, Giudice GJ. Zillikens D, et al. J Invest Dermatol. 1999 Jul;113(1):117-21. doi: 10.1046/j.1523-1747.1999.00618.x. J Invest Dermatol. 1999. PMID: 10417629 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters